Peripheral Neuropathy Market Size to Surpass US$ 2.38 Billion By 2032, Driven by Rising Diabetes and Nerve Damage Cases | Research by SNS Insider
11 juil. 2024 12h52 HE
|
SNS Insider pvt ltd
Pune, July 11, 2024 (GLOBE NEWSWIRE) -- Peripheral Neuropathy Market Analysis: “The Peripheral Neuropathy Market size was valued at US$ 1.48 billion in 2023, estimated to reach US$ 2.38 billion...
Diabetic Peripheral Neuropathy Therapeutics Research 2024: Comprehensive Insights about 10+ Companies and 15+ Pipeline Drugs
28 juin 2024 04h34 HE
|
Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Diabetic Peripheral Neuropathy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Diabetic Peripheral...
Comprehensive Diabetic Neuropathy Pipeline Insight Report for 2024 Reveals Progress in Treatment Landscape
27 juin 2024 10h46 HE
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Diabetic Neuropathy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.An in-depth pipeline insight report has been...
Chemotherapy Induced Peripheral Neuropathy Drug Pipeline Research 2024: Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type
26 juin 2024 09h26 HE
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.An insightful report...
Global Peripheral Nerve Injury Market to Surpass USD 3.57 Billion by 2034, Exhibiting a CAGR of 7.76%
20 mai 2024 07h50 HE
|
Research and Markets
Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The "Global Peripheral Nerve Injury Market" report has been added to ResearchAndMarkets.com's offering.The global peripheral nerve injury market is poised...
APAC Chemotherapy-Induced Peripheral Neuropathy (CIPN) Patient Pool Analysis, Market Size and Market Forecast Report 2024-2034
30 avr. 2024 07h44 HE
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy-Induced Peripheral Neuropathy (CIPN) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ...
Global Diabetic Neuropathy Treatment (Peripheral, Autonomic, NSAIDs, Capsaicin, Opioid) Market Size, Share & Trends Analysis Report 2024-2030
22 avr. 2024 10h20 HE
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Global Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report by Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy),...
Peripheral Neuropathy Market Size Worth USD 8.54 Billion in 2032 | Emergen Research
22 janv. 2024 10h57 HE
|
Emergen Research
Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global peripheral neuropathy market size was USD 3.61 Billion in 2022 and is expected to register a revenue CAGR of 9.0% during the forecast period....
Recent Publications Demonstrate Utility of DPNCheck® for Identifying High-Risk Diabetes Patients
28 juin 2023 09h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted the recent publication of two large studies that support the clinical utility of DPNCheck screening in people...
Quell® Demonstrates Encouraging Clinical Trial Results in Chemotherapy Induced Peripheral Neuropathy (CIPN)
31 mai 2023 09h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted publication of an abstract describing partial results from a NIH-funded, multi-site randomized controlled trial...